Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Multimedia
September 12, 2023
The first of CGD's conversations with candidates for the presidency of the European Investment Bank was with Margrethe Vestager. Margrethe is the Executive Vice-President of the European Commission and Commissioner for Competition. She has had a long and illustrious political career, having become a...
Blog Post
July 06, 2023
USAID administrator Samantha Power’s aim to advance localization—with at least a quarter of funds going directly to local partners—has been widely lauded. A recent USAID report on localization indicates progress towards this goal, but major operational and contractual directions about how to impleme...
Blog Post
March 09, 2023
Dana Hyde showed tremendous leadership and wisdom as the fourth head of the Millennium Challenge Corporation (MCC), serving for nearly three years during President Obama’s second term. These brief notes on her leadership are our way of providing a tribute to her major contributions to MCC’s effectiv...
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
CGD NOTES
December 14, 2022
Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibod...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
December 13, 2022
The case for multilateralism could not be clearer. It points to the many global problems that the world faces, which even the most powerful states cannot handle on their own. Containing global pandemics and mitigating climate change are tasks that require global cooperation. And yet, the future of t...